Biodesix
Earnings Roundup: Chembio Diagnostics, Exagen, Opko Health, Biodesix
Chembio, Exagen, and other firms reported quarterly financials this week.
Philips Incorporating Biodesix Nodify Test Into Lung Cancer Patient Management System
Philips said inclusion of data from the proteomic lung nodule assessment test can help improve diagnosis and treatment of lung cancer.
Biodesix, Memorial Sloan Kettering Team on Minimal Residual Disease Test
The MRD test will run on the Bio-Rad QX600 ddPCR System, and Biodesix may develop more tests for MSK under the agreement.
Biodesix, Sera Prognostics, Aspira, Epigenomics Post Q1 Financial Results
All four companies posted net losses for the quarter, while Biodesix's results were hit by a sharp decline in COVID-19 testing revenue.
Biodesix Raises $11.7M in Private Placement, Amends Loan Agreement
The stock was sold to a group of investors that includes members of Biodesix's board of directors.
Mar 8, 2022
Biodesix Inks $50M Stock Sale Agreement
May 11, 2021
Biodesix Q1 Revenues Soar on COVID-19 Testing
Mar 24, 2021
Biodesix Secures $30M Term Loan
Feb 26, 2021
Dec 11, 2020
Biodesix Q3 Revenues Rise Sharply
Nov 23, 2020
Three Investment Banks Initiate Coverage of Biodesix
Oct 28, 2020